Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Oncology|April 20, 2007
MR-guided microwave ablation for malignanciesYoshimasa Kurumi, Tohru Tani, Shigeyuki Naka, et al.Toxicology and Applied Pharmacology|August 16, 2016
Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in ratsHajime Abe, Fumiyo Saito, Takeshi Tanaka, et al.Molecular Pharmaceutics|July 4, 2018
Investigation of Receptor-Mediated Cyanocobalamin (Vitamin B<sub>12</sub>) Transport across the Inner Blood-Retinal Barrier Using Fluorescence-Labeled CyanocobalaminYuri Kinoshita, Kagayaki Nogami, Ryuta Jomura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[A case of breast cancer with repeated cardiac dysfunction due to trastuzumab]Aya Tokuda, Hajime Abe, Yuki Kawai, et al.The Journal of Toxicological Sciences|August 5, 2009
Changes in blood coagulation-related parameters in phenobarbital-treated rabbitsMasahiro Mochizuki, Hajime Abe, Kei Wakabayashi, et al.Toxicology and Applied Pharmacology|June 10, 2015
Cuprizone decreases intermediate and late-stage progenitor cells in hippocampal neurogenesis of rats in a framework of 28-day oral dose toxicity studyHajime Abe, Takeshi Tanaka, Masayuki Kimura, et al.Journal of Gastroenterology|November 17, 2007
Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreasTomoharu Shimizu, Satoshi Murata, Eiji Mekata, et al.No Shinkei Geka. Neurological Surgery|July 3, 2015
[An Endovascular Approach for Ruptured Aneurysms of the Basilar Trunk Perforating Artery]Naosuke Kanenaka, Hiroaki Sato, Hajime Abe, et al.International Journal of Molecular Medicine|September 10, 2003
Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucinKeiichi Kontani, Osamu Taguchi, Yoshitomo Ozaki, et al.Breast Cancer (Tokyo, Japan)|May 22, 2008
Bi-weekly docetaxel in the adjuvant treatment of node-positive or high-risk breast cancer patients: phase I study of the Shiga Breast Cancer Study GroupHajime Abe, Hiroki Ogawa, Takashi Okino, et al.Pageof 11